Acura Pharmaceuticals (OTCMKTS:ACUR) Shares Cross Above 200-Day Moving Average – What’s Next?

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR – Get Free Report) shares passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.0001. Acura Pharmaceuticals shares last traded at $0.00, with a volume of 0 shares trading hands.

Acura Pharmaceuticals Stock Down 100.0%

Get Acura Pharmaceuticals alerts:

About Acura Pharmaceuticals

(Get Free Report)

Acura Pharmaceuticals Inc is a specialty pharmaceutical company focused on developing and commercializing products designed to deter prescription drug abuse and misuse. The company’s core business centers on proprietary drug formulations that incorporate its Aversion and ARCUS® abuse-deterrent technologies. These platforms are intended to make it more difficult to tamper with or extract active pharmaceutical ingredients from oral dosage forms, helping to address public health concerns around opioid and stimulant abuse.

Acura’s lead product, Oxaydo®, is an immediate‐release oxycodone tablet that employs Aversion® technology to discourage tampering and intravenous abuse.

See Also

• Five stocks we like better than Acura Pharmaceuticals
• 3 Low-P/E Stocks That Look Cheap as the S&P 500 Trades Near Record Highs
• Travel + Leisure Goes Big—Is It Ready to Rally?
• 2 Biotech Stocks Shaping Up for Major Breakouts
• 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs

Receive News & Ratings for Acura Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acura Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.